Covid stocks11 Feb 2022 09:16
Just thought it was worth a comparison to one of our fellow covid stocks this morning.
ODX valued there business today at 5p per share. They will have 323m shares giving a mcap of roughly £16m. They have no debt and will have approx £7.5m in cash. So a EV of £8.5m.
NCYT have a mcap of £123m with £103m giving us a EV of £20m
ODX did about £5m Revenue in the last HY accounts. Of which about £1m is Covid related. They reported a HY loss of £3m. Similar to us they have been taken for mugs by our government which has ultimately resulted in 96% drop from peak covid values. £5m of their cash will be spent restructuring the business leaving just £2.5m to invest in new products and US growth. It won't be easy especially with only £2.5m to play with. They also have a dispute with the gov hanging over their heads worth £2.5m (money they don't have). They are basically in dire straights and have been done royally by the gov.
Now compare that situation with ours and tell me if you think the difference is £11.5m EV.
The market have tagged NCYT in with the rest of covid stocks but we appreciate that we arn't just another Covid stock. We got in there first and made £150m+ cash of which some we reinvested in organic growth. We have the products, we have the customers, we have the manufacturers, we have the distribution, we have the cash. Something that none of the others have. As a result NCYT is valued ludicrously imo.
Not to mention the recent LTIP that has a base SP more than 100% from today's price. Crazy